(74) research showed that treating CRC mice with Bifidobacterium longum decreased NF-κB and IL-6 concentrations, increased IL-1β concentrations, reduced the number of aberrant crypt foci, and slowed CRC progression. This evidence concerns the gene IL1B and colorectal carcinoma.